Entitled "Engineering Next-Generation Platforms for Disease Modeling and Drug Screening," the event provides a platform for interdisciplinary exchange between science, industry, and technology development.
The focus is on current developments and future prospects in the fields of 3D cell models and organ-on-chip systems. In particular, technologies that contribute significantly to the further development of these systems will be discussed:
• Automated biofabrication
• Bioelectronics and sensor technology for living tissue
• AI-supported image analysis
These three key technologies are considered central building blocks on the path to scalable, integrated platforms for disease modeling and drug discovery.
GENESIS 26 - The LIFE SCIENCE TECH DAY continues the successful series of iL events in the field of life sciences. At the last edition of the LSTD, on April 29, 2025, around 60 participants from Germany and abroad met at the "iL.Connect.Space" premises to advance the topic of "Further development of personalized medicine: A spotlight on organ-on-chip."